Yuefei Shen is a Principal Scientist within the CMC Drug Product Development Organization at Sanofi wherein she leads a team responsible for early drug product development for gene therapy programs. Prior to Sanofi, she worked at Novartis leading research projects. She obtained her Ph.D. in Chemistry from Washington University in St. Louis and Postdoc from the University of Massachusetts Medical School with focus on non-viral RNA therapy and gene therapy.

Talks

• Lipid nanoparticle development and impact on tissue targeting for non-viral gene therapy